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Background: Markers of inflammation are emerging as novel indices of cardio-
vascular risk. These markers have been shown to alter acutely after intense 
exercise; however, the effects of more moderate intensity exercise in healthy 
individuals is not known. Walking forms a cornerstone of physical activity 
promotion, so the inflammatory response to this exercise merits investigation. 
This study evaluated the effects of a 45-min walk on C-reactive protein (CRP) 
and interleukin 6 (IL-6), in sedentary, overweight men. Methods: Fifteen men 
(49.7 ± 5.9 y) walked for 45 min at 60 to 70% of predicted maximum heart rate. 
Fasted blood samples were taken prior to and immediately 1 hr and 24 h post-
walk. Results: IL-6 decreased from 1 h post-walk to 24 h post-walk (P < 0.01). 
No significant changes were observed in CRP. Conclusions: These findings 
suggest that 45 min walking at 60 to 70% HR
max-p 
causes a decrease in IL-6 24 h 
post-exercise, but does not evoke a significant response in CRP levels.
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There is increasing recognition that traditional risk factors do not fully account for 
the occurrence of cardiovascular disease (CVD). Almost one-half of the 1.3 million 
individuals who develop myocardial infarction in the US each year have either normal 
or only moderately increased cholesterol.1 Although atherogenesis was formerly 
considered a lipid storage disease, recent advances have highlighted the role of 
inflammation and underlying cellular and molecular mechanisms.2 Two markers of 
inflammation, interleukin 6 (IL-6) and C-reactive protein (CRP), have been linked 
with tissue damage and infection3 and the progression of atherosclerosis.4 Recent work 
has illustrated that IL-6 can predict future myocardial infarction and mortality risk in 
healthy individuals and those with coronary syndromes.5, 6 CRP has a strong associa-
tion with cardiovascular risk, which is consistent, dose-related, and independent.7
The health-related changes associated with exercise may be due in part to 
acute responses that persist following each exercise session.8 CRP and IL-6 have 
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been shown to alter acutely with exercise. IL-6 may increase following prolonged 
aerobic,9 maximal,10 eccentric,11 and anaerobic12 exercise while CRP has been shown 
to increase following prolonged aerobic13 and anaerobic exercise.12 These studies, 
however, have examined the response of trained individuals to high-intensity/volume 
exercise, where the activated phagocytic process is maximized. Exercise of a lower 
intensity where phagocytosis is minimized, might enhance the vascular clearance of 
some pro-inflammatory molecules, and provide a protective effect from further endo-
thelial damage. Few studies have considered how sedentary individuals would respond 
to moderate-intensity activity as recommended by public health guidelines.
Walking is a popular14 moderate-intensity exercise15 and forms the corner-
stone of many activity promotion strategies. The inflammatory response to walking 
therefore merits investigation. Two studies have utilized walking when examining 
the acute phase response.16, 17 The treadmill protocol of Fiotti and colleagues,16 
however, included a fixed stop of 1 min every 5 min, with peripheral artery dis-
ease (PAD) patients. Furthermore, CRP values were not reported. Similarly in the 
study of Signorelli and co-workers17 the subjects also had PAD, and walked to the 
onset of calf muscle cramps while the controls walked for a maximum of 5 min. 
No study has examined the effects of walking for durations ≥ 30 min on IL-6 and 
CRP in healthy but sedentary subjects. The purpose of the study, therefore, was to 
evaluate the acute effects of a single walking session on CRP and IL-6, in sedentary, 
overweight, but otherwise healthy men.
Methods
Study Design
The experimental protocol consisted of an initial screening assessment followed, 
at least 1 wk later, by a single exercise trial conducted over 2 d. The Research 
Ethics Committee at Queen’s University, Belfast, approved the study. Subjects 
were recruited from a register of outpatients at the Ulster Hospital and from staff 
at the University of Ulster, by means of telephone contact, email, and post. All 
subjects were sedentary,18 overweight males. Subjects gave their written informed 
consent and completed a health history questionnaire. Exclusion criteria were: 
age > 60 years, resting blood pressure ≥ 159/99 mm Hg, body-mass index (BMI) 
> 45 kg/m2, current smokers, individuals with known CVD, pain or discomfort in 
the chest, dizziness, or shortness of breath with usual activities. Also, those taking 
medications known to interfere with the cardiovascular disease risk markers being 
measured were excluded from the study. Physiological characteristics of the subjects 
who took part in the study (n = 15) are shown in Table 1.
A prospective power of the test calculation was performed19 and 15 subjects 
were identified as the required number to observe a statistical difference in IL-6 
between time intervals at 95% probability.
Preliminary Measures
During the screening visit, height and body mass were recorded using a stadiometer 
(Seca model 770, Vogel & Halke, Hamburg, Germany) and scales (Seca model 
707, Vogel & Halke) respectively. Waist circumference was measured at the level 
of the trunk where the girth is minimal. If there was no noticeable indent the tape 
326  Murtagh et al. 327 Walking and Markers of Inflammation
was located at the umbilicus. Hip circumference was measured according to estab-
lished procedures.20 Body-fat percentage was assessed by bioelectrical impedance 
analysis (Bodystat 1500, Bodystat Ltd., Isle of Man, UK) using recommended 
procedures.21 Resting blood pressure was recorded as the mean of 2 measurements 
using a validated automated device (Omron 705CP, Omron Matsusaka Co. Ltd., 
Japan), taken a minimum of 2 min apart, after the subject had rested in a supine 
position for at least 5 min. Subjects were then familiarized with walking on the 
treadmill at various speeds and slopes.
Experimental Trial
Subjects were instructed to fast for 10 h and refrain from strenuous physical activity 
for 24 h prior to testing. On day 1 of the exercise trial, subjects arrived at the Human 
Performance Laboratory between 7:30 AM and 9:00 AM. Subjects were asked to 
report any acute illnesses or infections, as these are associated with increased CRP 
levels.22 None were reported. Following 5 min rest in a supine position, a blood 
sample was obtained by venipuncture. Subjects then completed a 45-min treadmill 
walk at 60 to 70% of age-predicted maximum heart rate (HR
max-p
). The walk was 
preceded by a 3-min warm-up period. Heart rate was measured throughout the test 
by short-range telemetry (Accurex Plus; Polar Electro, Kempele, Finland). Ratings 
of perceived exertion (RPE) using the Borg 15-grade scale23 were recorded every 
5 min using recommended instructions.21 Energy expenditure was estimated using 
the subject body mass and walking speed.24 Venous blood samples were then taken 
immediately and 1 h post-exercise. On day 2 of the experimental trial, subjects 
returned to the laboratory after a 10 h fast. A final venous blood sample was taken 
24 h after completion of the 45-min treadmill walk.
Blood Analysis
Full blood count was measured on fresh EDTA samples on a Sysmex SE 9500 
(Sysmex, Milton Keynes, UK). Serum samples were separated, frozen at –22 °C, and 
Table 1 Physiological Characteristics of Subjects (n = 15)
Mean SD   Range
Age (y)  49.7  5.9    39 – 57
Body mass (kg)  100.1  19.5  80.6 – 163.1
Height (m)  1.8  0.1   1.7 – 1.9
BMI (kg/m2)  30.9  4.9  24.9 – 45.7
Body fat (%)  27.6  5.2  21.9 – 43.4
Waist girth (cm)  105.3  5.8  96.3 – 117.0
Hip girth (cm)  110.8  4.7 103.0 – 122.0
Waist:hip ratio  0.95  0.03  0.90 – 1.01
Systolic BP (mm Hg)  123.7  9.1 109.5 – 137.0
Diastolic BP (mm Hg)  76.4  5.8  70.0 – 90.5
Resting HR (beats/min)  64.7  7.3  52.5 – 80.5
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analyzed within 5 months for IL-6 and CRP. IL-6 was measured using a Quantikine 
high sensitivity kit (R & D Systems, Abingdon, UK) on a microplate autoreader 
(model EL 311, Bio-tek, Winooski, VT). Between-assay imprecision for IL-6 at 
concentrations of 0.49, 2.78, and 5.65 pg/L were 9.6, 7.2, and 6.5% CV. CRP was 
measured using a full-range, high sensitive immunoturbidimetry method (Randox 
Laboratories, Crumlin, UK) on a Hitachi 717 analyzer (Roche Products Ltd., Herts, 
UK). Between-assay imprecision for CRP was 1.82%, 1.85%, (n = 95) at mean 
concentrations of 2.18, 4.93 mg/L, and 2.38% at a mean of 21.50 mg/L (n = 70). 
Hematocrit was corrected by 1.5% for plasma trapped between erythrocytes.25 
Hemoglobin and hematocrit were then used to correct all variables for changes in 
plasma volume.26
Statistical Analysis
The data were analyzed using a one-way ANOVA with repeated measures. Where 
differences emerged, Bonferroni comparisons were used to identify which time 
points were significantly different. Statistical significance was established at 
P < 0.05. All descriptive data is presented as mean (± standard deviation) and all 
outcome measures are presented as mean (± standard error of the mean) unless 
otherwise stated.
Results
Interleukin 6
Mean pre-exercise IL-6 was 1.92 ± 0.29 pg/mL. Corresponding values at imme-
diately post-, 1 h post-, and 24 h post-exercise were 1.73 ± 0.18, 1.76 ± 0.16, and 
1.37 ± 0.14 pg/mL, respectively. There was a significant decrease from 1 h post-
exercise to 24 h post-exercise. The IL-6 response to the 45-min treadmill walk is 
illustrated in Figure 1.
C-Reactive Protein
Mean CRP at pre-exercise was 1.95 ± 0.63 mg/L. Corresponding values were 
1.91 ± 0.61, 1.92 ± 0.63, and 2.36 ± 0.76 mg/L at immediately post-, 1 h post-, and 
24 h post-exercise, respectively. No significant effects were observed.
Full Blood Count
White blood cells significantly increased from baseline (5.66 ± 0.27 × 109/L) to 
immediately post-exercise (6.29 ± 0.30 × 109/L) and remained increased at 1 h 
post-exercise (6.29 ± 0.30 × 109/L). Neutrophils significantly increased from 
baseline (3.24 ± 0.18 × 109/L) to immediately post-exercise (3.76 ± 0.23 × 109/L) 
and remained significantly elevated at 1 h post-exercise (3.84 ± 0.24 × 109/L). 
Baseline levels of lymphocytes, monocytes, eosinophils, and basophils were 1.7 
± 0.14, 0.47 ± 0.04, 0.2 ± 0.02, and 0.05 ± 0.01 × 109/L, respectively. There were 
no significant effects observed.
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Exercise Intensity
The mean HR recorded during the 45-min walk was 112.2 ± 5.7 beats/min. This 
corresponded to an exercise intensity of 65.8 ± 1.7% HR
max-p
. The mean RPE during 
the treadmill test was 11.4 ± 1.0. The mean estimated energy expenditure during 
the 45-min walk was 315 (± 61.45) kcal.
Discussion
The unique aspect of the current study was that the acute response of novel inflam-
matory markers of CVD risk was examined following exercise of a type prescribed 
in current physical activity promotion strategies. The main findings are that walking 
for 45 min at a moderate intensity (~ 66% HR
max-p
) causes a significant decrease in 
IL-6 levels at 24 h post-exercise, and does not alter the acute-phase protein CRP.
The mean BMI of subjects in the present investigation was 30.9, which clas-
sifies them as “Class 1 obese” according to the Expert Panel on the Identification, 
Evaluation, and Treatment of Overweight and Obesity in Adults.27 Overweight 
males were deliberately chosen for the present investigation due to their increased 
CVD risk. Several studies have noted a positive relationship between adiposity and 
CRP,28 and its primary stimulus, IL-6.29 The fact that up to 30% of total circulating 
IL-6 originates from adipose tissue7 could mean that obesity resembles a low-grade 
inflammatory state.4 This might be a considerable public health burden given the 
rising prevalence of overweight and obesity.30
IL-6 is a potent stimulator of the acute phase response and has recently 
emerged as a novel risk factor for CVD risk. Risk stratification levels for IL-6 
in CVD risk have yet to be established, although comparison can be drawn to a 
recent prospective study of 14,916 apparently healthy men followed-up over 6 y 
Figure 1 — Interleukin 6 (IL-6) before and after 45 minutes walking. Values are means ± 
standard error of the mean. *Significant difference from 1 h post-exercise (P < 0.01).
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for future myocardial infarction.5 The mean baseline IL-6 level of subjects in the 
present investigation (1.92 ± 0.29 pg/mL) were in the third quartile of Ridker and 
colleagues’ cohort, which is associated with a relative risk of 2.8 compared to those 
in the lowest quartile. There was no significant change in IL-6 levels immediately 
after, or 1 h following the 45 min walk. There was a significant decrease, however, 
from 1 h post-exercise to 24 h post-exercise. These findings are in contrast to the 
preponderance of research in the area which show elevated IL-6 levels immediately 
post-exercise.31,32 The intensity/volume of exercise performed by the subjects in 
the present investigation was considerably less than the aforementioned studies, 
which could account for the conflicting findings. This is consistent with previous 
suggestions that the magnitude of IL-6 response is dependent on the intensity of 
effort.33
Only one other study has been identified which demonstrated attenuated 
IL-6 levels post-exercise. The effects of 30 min of treadmill walking (3 km/h) was 
examined in patients with peripheral arterial disease and control subjects.16 The 
treadmill walk included a fixed stop of 1 min every 5 min, as these conditions were 
the heaviest strain tolerable by patients. IL-6 significantly decreased immediately 
post-exercise in both patients and controls, and this reduction was also present 4 h 
later. The authors, however, could not hypothesize as to the reason for the observed 
reduction in IL-6 nor the implication of this finding. The present study shows 
the unique finding of a significant reduction in IL-6 levels at 24 h post-exercise. 
As Fiotti and colleagues did not obtain a blood sample after 4 h, it is not known 
whether IL-6 levels would have been significantly reduced at 24 h in their subjects. 
Similarly, whether IL-6 concentration returned to baseline levels in the hours after 
the last sampling time in the present investigation is unknown.
Although systemic changes similar to an acute phase response after a single 
exercise session tend to be small and transient, local tissue responses might be of 
sufficient magnitude and duration to have biological relevance.34 A fall in IL-6 
at 48 h after admission to hospital with unstable angina was associated with an 
uncomplicated in-hospital course, while an increase was associated with an elevated 
risk of coronary events.35 Further work is required to examine whether a transient 
exercise-induced decrease in IL-6 levels, of the order found in the present study, 
translates into a meaningful attenuation in CVD risk. It is worth considering that 
given the attenuation of IL-6 levels at 24 h post-exercise, IL-6 might be kept at 
suppressed levels if an individual were to walk on a daily basis. The mechanism 
underlying the decrease in IL-6 found in the current study is at present unclear and 
further work is required to elucidate the issue.
Baseline CRP values in the present study were 1.95 ± 0.63 mg/L. CRP 
levels of < 1, 1 to 3, and > 3 mg/L correspond to low-, moderate-, and high-risk 
groups, respectively, for future cardiovascular events.22 The mean baseline CRP 
level classifies subjects as being at moderate risk of future cardiovascular events. 
There were, however, no significant effects observed for the acute effect of 45 min 
walking on CRP levels.
In keeping with the results of the present investigation, five other studies did 
not find a significant elevation in CRP levels following exercise. Sixty minutes of 
level and 40 min of downhill treadmill running did not evoke significant changes 
in CRP.36 Similarly, elevated CRP was not seen as an acute consequence of typical 
training of elite female netball and soccer teams.37 Twenty-four maximal eccen-
tric arm curls did not evoke significant alterations in CRP levels in 14 untrained 
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males.38 Five minutes of treadmill walking did not evoke a significant change in 
CRP values immediately post-exercise, in healthy elderly control subjects.17 Finally, 
CRP level did not alter following 30 min of treadmill walking in patients with 
peripheral artery disease and controls.16 It has been suggested that a dose–response 
relationship might exist for the acute phase responses following exercise, where the 
dose of exercise is the product of exercise intensity multiplied by duration.34 The 
reasons for the lack of change in CRP following exercise observed in the present 
study are not clear; however, one cannot exclude the possibility of a change in the 
production-clearance ratio of this metabolite. It could also be that the sample size 
was insufficient to detect a change in CRP over time.
Cytokines operate both as a cascade and as a network in stimulating the 
production of acute-phase proteins.39 As IL-6 is the primary stimulus for CRP, their 
effects should not be discussed in isolation. Cytokine-induced gene expression and 
subsequent de novo protein synthesis takes time; thus significant elevation of acute 
phase plasma proteins require 12 to 24 h to occur.34 A significant reduction in IL-6 
levels was noted at 24 h post-exercise in the present investigation. It is therefore 
plausible that had there been a subsequent sampling time, allowing another 12 to 
24 h, an effect on CRP levels might have been detected. This snapshot approach 
with 3 post-exercise blood samples does not allow a complete picture of the IL-6 
changes to be described. In the study of Fiotti and co-workers16 reduced IL-6 levels 
were found immediately post-, and 4 h post-exercise, while no changes in CRP was 
reported. Again, it is likely that had another sampling time been included, possibly 
12 to 24 h later, an effect on CRP concentrations could have been detected. These 
observations highlight important areas for future research.
In summary, the findings of the present investigation suggest that 45 min 
moderate-intensity walking at ~ 66% HR
max-p 
causes a decrease in IL-6 at 24 h 
post-exercise, and does not evoke a significant acute-phase response as measured 
by CRP concentrations. Whether the acute reduction in IL-6 translates into attenu-
ated CVD risk is an important avenue for future work, given the potential benefits 
for public health.
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